Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 218506 (Jun 13, 2024)

Issued June 13, 2024

Issued

June 13, 2024

Application

NDA 505b1 • 218506

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…